Clinical trial
Investigation of the Prognostic Value of pVO2 in Recipients of Left Ventricular Assist Devices
NCT04423562 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Prognostic Value of pVO2 in Recipients of Left Ventricular Assist Devices
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 10, 2020
- Completion date
- December 31, 2022
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced heart failure, left ventricular assist device, prognosis